TRX2 was before my time on this forum, so I am not that familiar with the details, but from skimming a few of the posts I can tell there are a few similarities. I think it is a good cautionary tale. Still, follicept do not strike me as being in the same category.
Here is mye prediction for what is going to happen:
The follicept trial will be disappointing and inconclusive and we will see vague reports with things like "I think my shedding has slowed", "I think I see some vellus hair" etc. But when this happens, follicept will stay true to their word and they will not sell it. Instead they will use their vehicle with another growth stimulant in a new test. Maybe they will make a deal with some other company, like the ones who are developing CB-03-01 who had some dosage/vehicle problems.
But... I hope I am wrong.

Leave a comment: